Showing all 3 results
Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Paroxetine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the extended-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 12.5 mg (CR) Initiation Standard: Base titration unit to safely acclimatize the brain and minimize initial side effects. Gold standard for PMDD. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 25 mg (CR) Global Clinical Standard: Standard adult maintenance dose for Major Depressive Disorder and Severe Panic Disorder. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 37.5 mg (CR) Advanced Psychiatric Standard: High-dose maintenance therapy for treatment-resistant depression and refractory anxiety. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Lactose Monohydrate / Magnesium Stearate / Triethyl Citrate Hydrophilic SR Polymer Matrix / Enteric Coating / Diluent / Plasticizer (Engineered to absolutely block stomach acid and control the exact 24-hour intestinal diffusion rate) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Venalafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Extended-Release (ER) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the controlled-release polymer matrix.
Active Ingredient Strength Primary Clinical Use Venlafaxine Hydrochloride USP/BP/Ph.Eur. 37.5 mg (Extended-Release) Mandatory initiation dose for severe panic disorder and strict tapering/weaning protocols. Venlafaxine Hydrochloride USP/BP/Ph.Eur. 75 mg (Extended-Release) Standard Adult Dose for initiating therapy in Major Depressive Disorder and GAD. Venlafaxine Hydrochloride USP/BP/Ph.Eur. 150 mg (Extended-Release) High-dose SNRI therapy for treatment-resistant depression and severe social anxiety. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release)
